Literature DB >> 24488047

Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning.

B Askaa1, A Fischer-Nielsen2, L Vindeløv1, E K Haastrup2, H Sengeløv1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24488047     DOI： 10.1038/bmt.2014.5

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  CD34+ selected haematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment for graft failure.

Authors:  G Milone; A Tornello; S Leotta; M Poidomani; S Mercurio; B Farsaci; C Consoli; P Murgano; R Giustolisi
Journal:  Bone Marrow Transplant       Date:  2005-03       Impact factor: 5.483

2.  Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantation.

Authors:  Uwe Platzbecker; Marc Binder; Christoph Schmid; Claudia Rutt; Gerhard Ehninger; Martin Bornhäuser
Journal:  Haematologica       Date:  2008-06-02       Impact factor: 9.941

3.  Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.

Authors:  Alessandra Larocca; Giovanna Piaggio; Marina Podestà; Anna Pitto; Barbara Bruno; Carmen Di Grazia; Francesca Gualandi; Domenico Occhini; Anna Maria Raiola; Alida Dominietto; Stefania Bregante; Teresa Lamparelli; Elisabetta Tedone; Rosi Oneto; Francesco Frassoni; Maria Teresa Van Lint; Enrico Pogliani; Andrea Bacigalupo
Journal:  Haematologica       Date:  2006-07       Impact factor: 9.941

4.  Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs.

Authors:  Hirohisa Nakamae; Barry Storer; Brenda M Sandmaier; David G Maloney; Chris Davis; Lawrence Corey; Rainer Storb; Michael Boeckh
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

5.  Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation.

Authors:  P Dreger; M Suttorp; T Haferlach; H Löffler; N Schmitz; W Schroyens
Journal:  Blood       Date:  1993-03-01       Impact factor: 22.113

6.  Second unrelated donor hematopoietic cell transplantation for primary graft failure.

Authors:  Jeffrey Schriber; Manza-A Agovi; Vincent Ho; Karen K Ballen; Andrea Bacigalupo; Hillard M Lazarus; Christopher N Bredeson; Vikas Gupta; Richard T Maziarz; Gregory A Hale; Mark R Litzow; Brent Logan; Martin Bornhauser; Roger H Giller; Luis Isola; David I Marks; J Douglas Rizzo; Marcelo C Pasquini
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-19       Impact factor: 5.742

7.  Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Authors:  Marie Robin; Reza Tabrizi; Mohamad Mohty; Sabine Furst; Mauricette Michallet; Jacques-Olivier Bay; Jean-Yves Cahn; Eric De Coninck; Nathalie Dhedin; Marc Bernard; Bernard Rio; Agnès Buzyn; Anne Huynh; Karin Bilger; Pierre Bordigoni; Nathalie Contentin; Raphaël Porcher; Gérard Socié; Noel Milpied
Journal:  Br J Haematol       Date:  2010-12-07       Impact factor: 6.998

8.  CD34(+) immunoselected cells for poor graft function following allogeneic BMT.

Authors:  M Mohty; C Faucher; C Chabannon; N Vey; A M Stoppa; P Ladaique; G Novakovitch; S Olivero; R Bouabdallah; J A Gastaut; D Maraninchi; D Blaise
Journal:  Cytotherapy       Date:  2000       Impact factor: 5.414

9.  Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis.

Authors:  Gabriela Rondón; Rima M Saliba; Issa Khouri; Sergio Giralt; Kawah Chan; Elias Jabbour; John McMannis; Richard Champlin; Elizabeth Shpall
Journal:  Biol Blood Marrow Transplant       Date:  2008-08       Impact factor: 5.742

10.  Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation.

Authors:  M Remberger; O Ringdén; P Ljungman; H Hägglund; J Winiarski; B Lönnqvist; J Aschan
Journal:  Bone Marrow Transplant       Date:  1998-07       Impact factor: 5.483
  10 in total
  6 in total

1.  The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function.

Authors:  Y Kong; Y-T Wang; Y Hu; W Han; Y-J Chang; X-H Zhang; Z-F Jiang; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2015-10-05       Impact factor: 5.483

2.  Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.

Authors:  Sebastian P Haen; Michael Schumm; Christoph Faul; Lothar Kanz; Wolfgang A Bethge; Wichard Vogel
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-14       Impact factor: 4.553

3.  Fresh or Cryopreserved CD34+-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Armin Ghobadi; Mark A Fiala; Giridharan Ramsingh; Feng Gao; Camille N Abboud; Keith Stockerl-Goldstein; Geoffrey L Uy; Brenda J Grossman; Peter Westervelt; John F DiPersio
Journal:  Biol Blood Marrow Transplant       Date:  2017-03-18       Impact factor: 5.742

Review 4.  Improving allogeneic stem cell transplantation in myelofibrosis.

Authors:  Nico Gagelmann; Nicolaus Kröger
Journal:  Int J Hematol       Date:  2022-04-13       Impact factor: 2.490

5.  Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants.

Authors:  Yuan Kong; Yang Song; Yue Hu; Min-Min Shi; Yu-Tong Wang; Yu Wang; Xiao-Hui Zhang; Lan-Ping Xu; Kai-Yan Liu; Hong-Kui Deng; Xiao-Jun Huang
Journal:  Oncotarget       Date:  2016-05-24

Review 6.  Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation.

Authors:  Ashvind Prabahran; Rachel Koldej; Lynette Chee; David Ritchie
Journal:  Blood Adv       Date:  2022-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.